Page last updated: 2024-12-07

1-(3-cyclohexen-1-ylcarbonyl)-2-methylpiperidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

The chemical name **1-(3-cyclohexen-1-ylcarbonyl)-2-methylpiperidine** describes a specific organic molecule. Let's break down its structure and potential importance:

**Structure:**

* **1-(3-cyclohexen-1-ylcarbonyl)-** This part indicates a carbonyl group (C=O) attached to a cyclohexene ring (a six-membered ring with one double bond) at the 3rd position. The 1- indicates the carbonyl group is attached to the nitrogen atom in the next part of the molecule.
* **2-methylpiperidine** This part describes a piperidine ring (a six-membered ring with one nitrogen atom) that has a methyl group (CH3) attached at the 2nd position.

**In summary:** This molecule consists of a cyclohexenyl ring connected to a piperidine ring through a carbonyl group. The piperidine ring also has a methyl group.

**Potential Importance for Research:**

It's impossible to say definitively why this specific molecule is important for research without further context. However, given its structure, it could be relevant for several reasons:

* **Pharmacological studies:** Piperidine rings and cyclohexenyl groups are commonly found in pharmaceuticals. This molecule could be a starting point for developing new drugs.
* **Organic chemistry research:** This molecule could be a synthetic target for studying reactions or new methods of building complex structures.
* **Materials science:** Some molecules with these structural features might have interesting properties, such as being used in polymers or as catalysts.

**To understand why this molecule is specifically important, you need more information:**

* **What is the research goal?** Is it drug discovery, materials development, or something else?
* **What are the properties of this molecule?** Does it have any biological activity, interesting chemical reactivity, or unique physical properties?
* **What are the researchers investigating?** What are the specific questions they are trying to answer?

Once you have more context, it will be easier to understand the significance of this molecule for research.

Cross-References

ID SourceID
PubMed CID90567
SCHEMBL ID2374415
MeSH IDM0204286

Synonyms (14)

Synonym
ai3-37220
ai3 37220
piperidine, 1-(3-cyclohexen-1-ylcarbonyl)-2-methyl-
1-(3-cyclohexen-1-ylcarbonyl)-2-methylpiperidine
3-cyclohexen-1-yl(2-methyl-1-piperidinyl)methanone
cyclohex-3-en-1-yl-(2-methylpiperidin-1-yl)methanone
69462-43-7
cyclohex-3-en-1-yl(2-methylpiperidin-1-yl)methanone
AKOS015915065
SCHEMBL2374415
Z183726212
1-[3-cyclohexen-1-ylcarbonyl]-2-methylpiperidine
DTXSID10989372
methanone, 3-cyclohexen-1-yl(2-methyl-1-piperidinyl)-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's10 (52.63)18.2507
2000's9 (47.37)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.13 (24.57)
Research Supply Index3.14 (2.92)
Research Growth Index4.27 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other22 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]